Astera Labs, Inc. $ALAB Position Trimmed by Summitry LLC

Summitry LLC trimmed its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 28.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 64,000 shares of the company’s stock after selling 25,000 shares during the quarter. Summitry LLC’s holdings in Astera Labs were worth $12,531,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Clearstead Trust LLC raised its position in Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after acquiring an additional 461 shares in the last quarter. Advisors Asset Management Inc. lifted its stake in Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after acquiring an additional 194 shares during the last quarter. Manchester Capital Management LLC grew its position in Astera Labs by 141.5% in the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after acquiring an additional 283 shares in the last quarter. Finally, Whittier Trust Co. bought a new stake in Astera Labs in the third quarter worth approximately $55,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Astera Labs Trading Up 2.2%

Shares of NASDAQ ALAB opened at $129.32 on Monday. The firm has a market capitalization of $21.84 billion, a price-to-earnings ratio of 106.00, a PEG ratio of 2.54 and a beta of 1.51. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The business has a fifty day simple moving average of $164.09 and a 200 day simple moving average of $174.83.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the previous year, the company earned $0.37 earnings per share. The business’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have commented on ALAB. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Northland Securities upped their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Barclays set a $165.00 price objective on Astera Labs in a research note on Thursday, January 15th. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Finally, Needham & Company LLC upped their target price on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Fourteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $192.89.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 12.50% of the stock is owned by company insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.